Articles for category: biotech sector, Grey Market Premium, investor sentiment, IPO, Onyx Biotec, Uncategorized

Onyx Biotec IPO: Is the 11% Discount a Sign of Trouble? Exploring the Latest GMP Insights!

Introduction to Onyx Biotec IPO The financial world is buzzing with the recent debut of Onyx Biotec’s IPO, which has brought a mix of excitement and skepticism among investors. As shares of Onyx Biotec made their entry onto the NSE SME platform, they opened at an 11% discount, raising eyebrows and igniting discussions about the ...

Onyx Biotec IPO: What Does the 11% Discount Debut Mean for Investors? Unpacking the Buzz Around GMP!

Introduction: A New Player in the Market The Onyx Biotec IPO has made headlines as it hit the market, but not in the way many anticipated. Launching on November 24, 2024, the shares debuted at an 11% discount on the NSE SME platform, raising eyebrows and sparking conversations among investors and analysts alike. What does ...